Cytoprotective effect of Fridericia chica (Bonpl.) L.G. Lohmann extract associated with geranylgeraniol enriched-fraction from Bixa orellana L. on epithelial cells treated with bisphosphonate

Bisphosphonates are drugs used to treat bone disorders. The chronic use of bisphosphonates is associated with the occurrence of medication-related osteonecrosis of the jaw (MRONJ). Previous data reported the positive effects of Geranylgeraniol on different cell types treated with Bisphosphonates. Fo...

Full description

Saved in:
Bibliographic Details
Published in:Natural product research Vol. 37; no. 16; pp. 2776 - 2781
Main Authors: Machado Júnior, Rogério José, Camilli, Júlia C, Basting, Rosanna Tarkany, Zago, Patrícia Maria Wiziacki, Sousa, Ilza Maria de Oliveira, Buglio, Kaio Eduardo, Ruiz, Ana Lúcia T G, Carvalho, Paulo Roberto Nogueira, Carvalho, João Ernesto de, Saad, Sara T O, Foglio, Mary Ann
Format: Journal Article
Language:English
Published: England Taylor & Francis Ltd 01-08-2023
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Bisphosphonates are drugs used to treat bone disorders. The chronic use of bisphosphonates is associated with the occurrence of medication-related osteonecrosis of the jaw (MRONJ). Previous data reported the positive effects of Geranylgeraniol on different cell types treated with Bisphosphonates. Foregoing work done by our research group demonstrated the wound healing capacity of (Bonpl.) L.G.Lohmann standardized ethanol extract. Herein cytoprotective synergistic effect of the association of extract associated with an enriched geranylgeraniol fraction on keratinocytes exposed to zoledronic acid is reported. An association of at 1 and 5 µg/mL with geranylgeraniol at 15 µg/mL, increased cell viability by 73.5% and 71.1%, respectively. This treatment did not increase tumor cells viability; whereas the clonogenic potential assessment showed that, the association with (5 µg/mL) reversed the effects of zoledronic acid on the cells. This study provides data for a potential treatment for MRONJ.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1478-6419
1478-6427
DOI:10.1080/14786419.2022.2131782